Bally’s Corporation (NYSE: BALY) eyes evoke plc (LSE: EVOK): why a William Hill deal would reshape UK gambling
Why SK Life Science Labs’ AACR 2026 data could put targeted protein degradation back in the oncology spotlight
Read More Pharma Industry News Orchard Therapeutics raises $150m in Series C funding to advance gene therapies for rare diseases Orchard Therapeutics, a leader in gene therapy specializing in rare diseases, has successfully secured $150 million through a… bypharmanewsdailyAugust 15, 2018
